Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer
Authors:
Open Access
- 15 July 2007
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (14) , 4139-4145
Abstract
Purpose: There is evidence that IFNγ plays an important role in ovarian cancer development. IFNγ produces numerous antitumor effects and it may be evasion of these effects which allows tumor progression. We postulate that genetic instability in tumor cells may lead to modulation of expression of the IFNγ receptor, thus leading to altered tumor biology and patient prognosis. This hypothesis would support the theory of immunoediting in ovarian cancer.Keywords
This publication has 23 references indexed in Scilit:
- Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II studyInternational Journal of Gynecological Cancer, 2006
- Involvement of both intrinsic and extrinsic pathways in IFN-γ-induced apoptosis that are enhanced with cisplatinEuropean Journal of Cancer, 2005
- Interferon-γ expression is an independent prognostic factor in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2004
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- γδ T Cells Provide an Early Source of Interferon γ in Tumor ImmunityJournal of Experimental Medicine, 2003
- The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cellsOncogene, 2002
- Immunotherapy of ovarian cancerExpert Opinion on Biological Therapy, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Modulation of cisplatin cytotoxicity by human recombinant interferon-γ in human ovarian cancer cell linesEuropean Journal of Cancer, 1994